Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-31

Clinical Trial Update: Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy [NA]

View source ↗

Summary

A clinical trial is evaluating induction of sustained unresponsiveness to sesame using high- and low-dose sesame oral immunotherapy; enrollment is by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sesame oral immunotherapy (OIT) (sesame oral immunotherapy)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Food Allergy | NA | Status: ENROLLING_BY_INVITATION